Privia Health Group, Inc.

NasdaqGS:PRVA Stock Report

Market Cap: US$2.2b

Privia Health Group Future Growth

Future criteria checks 4/6

Privia Health Group is forecast to grow earnings and revenue by 31.7% and 9.4% per annum respectively. EPS is expected to grow by 29.8% per annum. Return on equity is forecast to be 4.6% in 3 years.

Key information

31.7%

Earnings growth rate

29.8%

EPS growth rate

Healthcare earnings growth19.3%
Revenue growth rate9.4%
Future return on equity4.6%
Analyst coverage

Good

Last updated26 Sep 2024

Recent future growth updates

Recent updates

It's A Story Of Risk Vs Reward With Privia Health Group, Inc. (NASDAQ:PRVA)

Sep 12
It's A Story Of Risk Vs Reward With Privia Health Group, Inc. (NASDAQ:PRVA)

There May Be Reason For Hope In Privia Health Group's (NASDAQ:PRVA) Disappointing Earnings

Aug 16
There May Be Reason For Hope In Privia Health Group's (NASDAQ:PRVA) Disappointing Earnings

Some Investors May Be Worried About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Jul 12
Some Investors May Be Worried About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Privia Health Group, Inc.'s (NASDAQ:PRVA) Subdued P/S Might Signal An Opportunity

Jun 11
Privia Health Group, Inc.'s (NASDAQ:PRVA) Subdued P/S Might Signal An Opportunity

Privia Health: Key Lessons Learned (Rating Downgrade)

May 22

Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers

Mar 03
Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers

The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)

Feb 27
The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)

There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Jan 31
There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching

Dec 03
Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching

Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues

Nov 06
Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues

Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business

Aug 08
Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business

Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate

Mar 17
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate

Privia Health: In Line For Solid FY22, Hold On Valuation

Sep 15

Privia Health Group reports Q2 earnings beat; raises FY22 outlook

Aug 11

Privia Health Group Grows But Operating Results Await

Jun 20

Earnings and Revenue Growth Forecasts

NasdaqGS:PRVA - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,1264710710811
12/31/20251,87632918917
12/31/20241,67220686617
6/30/20241,696158888N/A
3/31/20241,687196161N/A
12/31/20231,658238181N/A
9/30/20231,581384646N/A
6/30/20231,507343940N/A
3/31/20231,429163939N/A
12/31/20221,357-94747N/A
9/30/20221,268-3856N/A
6/30/20221,176-495252N/A
3/31/20221,066-2115252N/A
12/31/2021966-1885555N/A
9/30/2021905-1726464N/A
6/30/2021860-1473737N/A
3/31/2021818314343N/A
12/31/2020817313939N/A
12/31/201978681924N/A
12/31/2018658-355N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PRVA's forecast earnings growth (31.7% per year) is above the savings rate (2.5%).

Earnings vs Market: PRVA's earnings (31.7% per year) are forecast to grow faster than the US market (15.2% per year).

High Growth Earnings: PRVA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: PRVA's revenue (9.4% per year) is forecast to grow faster than the US market (8.8% per year).

High Growth Revenue: PRVA's revenue (9.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: PRVA's Return on Equity is forecast to be low in 3 years time (4.6%).


Discover growth companies